The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity
Open accessAbstract
RNA transcripts encoding the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor (5-HT2CR) undergo adenosine-to-inosine RNA editing events at up to five specific sites. Compared with rat brain, human brain samples expressed higher levels of RNA transcripts encoding the amino acids valine-serine-valine (5-HT2C-VSV) and valine-glycine-valine (5-HT2C-VGV) at positions 156, 158, and 160, respectively. Agonist stimulation of the nonedited human receptor (5-HT2C-INI) and the edited 5-HT2C-VSV and 5-HT2C-VGV receptor variants stably expressed in NIH-3T3 fibroblasts demonstrated that serotonergic agonists were less potent at the edited receptors. Competition binding experiments revealed a guanine nucleotide-sensitive serotonin high affinity state only for the 5-HT2C-INI receptor; the loss of high affinity agonist binding to the edited receptor demonstrates that RNA editing generates unique 5-HT2CRs that couple less efficiently to G proteins. This reduced G protein coupling for the edited isoforms is primarily due to silencing of the constitutive activity of the nonedited 5-HT2CR. The distinctions in agonist potency and constitutive activity suggest that different edited 5-HT2CRs exhibit distinct responses to serotonergic ligands and further imply that RNA editing represents a novel mechanism for controlling physiological signaling at serotonergic synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,003
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
Sommer, B., Köhler, M., Sprengel, R., & Seeburg, P. H. (1991) · Cell · doi:10.1016/0092-8674(91)90568-j · Cited by 1,517
Ca2 + Permeability of KA-AMPA—Gated Glutamate Receptor Channels Depends on Subunit Composition
Hollmann, M., Hartley, M., & Heinemann, S. (1991) · Science · doi:10.1126/science.1709304 · Cited by 1,456
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Regulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010
Self-citationStructural Determinants of Ion Flow Through Recombinant Glutamate Receptor Channels
Verdoorn, T. A., Burnashev, N., Monyer, H., Seeburg, P. H., & Sakmann, B. (1991) · Science · doi:10.1126/science.1710829 · Cited by 813
Cited by
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
RNA Editing by Adenosine Deaminases That Act on RNA
Bass, B. L. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135501 · Cited by 1,268
Functions and Regulation of RNA Editing by ADAR Deaminases
Nishikura, K. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-105251 · Cited by 1,242
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Molecular biology of 5-HT receptors
Hannon, J., & Hoyer, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.020 · Cited by 815
Seifert, R., & Wenzel-Seifert, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0588-0 · Cited by 637
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
CHEN, C.-X., CHO, D.-S. C., WANG, Q., LAI, F., CARTER, K. C., & NISHIKURA, K. (2000) · RNA · doi:10.1017/s1355838200000170 · Cited by 524
Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene
Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D. L., Weiss, M. J., & Nishikura, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310162200 · Cited by 501
Multiplicity of mechanisms of serotonin receptor signal transduction
Raymond, J. R., Mukhin, Y. V., Gelasco, A., Turner, J., Collinsworth, G., Gettys, T. W., Grewal, J. S., & Garnovskaya, M. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00169-3 · Cited by 466
Murray, K. C., Nakae, A., Stephens, M. J., Rank, M., D'Amico, J., Harvey, P. J., Li, X., Harris, R. L. W., Ballou, E. W., Anelli, R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2160 · Cited by 407
The role of serotonin receptors in the action of atypical antipsychotic drugs
Meltzer, H., & Massey, B. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.02.007 · Cited by 381
Palladino, M. J., Keegan, L. P., O'Connell, M. A., & Reenan, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00049-0 · Cited by 380
Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., & Schmauss, C. (2002) · Neuron · doi:10.1016/s0896-6273(02)00660-8 · Cited by 377
Porter, R. H. P., Benwell, K. R., Lamb, H., Malcolm, C. S., Allen, N. H., Revell, D. F., Adams, D. R., & Sheardown, M. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702751 · Cited by 358
The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?
Roth, B. L., Lopez, E., Patel, S., & Kroeze, W. K. (2000) · The Neuroscientist · doi:10.1177/107385840000600408 · Cited by 358
Serotonin and brain development
Sodhi, M. S. K., & Sanders-Bush, E. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59006-2 · Cited by 340
Self-citationMutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral
Samuel, C. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.004 · Cited by 315
De Deurwaerdère, P., Navailles, S., Berg, K. A., Clarke, W. P., & Spampinato, U. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0112-04.2004 · Cited by 306
Adenosine-to-inosine RNA editing and human disease
Slotkin, W., & Nishikura, K. (2013) · Genome Medicine · doi:10.1186/gm508 · Cited by 296
Large-scale mRNA sequencing determines global regulation of RNA editing during brain development
Wahlstedt, H., Daniel, C., Ensterö, M., & Öhman, M. (2009) · Genome Research · doi:10.1101/gr.089409.108 · Cited by 287
Bockaert, J., Claeysen, S., Bécamel, C., Dumuis, A., & Marin, P. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0286-1 · Cited by 284
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 283
Functional diversity of small nucleolar RNAs
Bratkovič, T., Božič, J., & Rogelj, B. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1140 · Cited by 272
Generation of neuronal variability and complexity
Muotri, A. R., & Gage, F. H. (2006) · Nature · doi:10.1038/nature04959 · Cited by 274
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Self-citationA-to-I RNA Editing and Human Disease
Maas, S., Kawahara, Y., Tamburro, K. M., & Nishikura, K. (2006) · RNA Biology · doi:10.4161/rna.3.1.2495 · Cited by 262
Niswender, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00223-2 · Cited by 256
Self-citationThe serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease
Khermesh, K., D'Erchia, A. M., Barak, M., Annese, A., Wachtel, C., Levanon, E. Y., Picardi, E., & Eisenberg, E. (2016) · RNA · doi:10.1261/rna.054627.115 · Cited by 160
“…fraction of editing sites in protein coding genes that result in amino acid substitutions, also known as the recoding sites (Sommer et al. 1991; Niswender et al. 1999; Berg et al. 2001; Hoopengardner et al. 2003; Iwamoto and Kato 2003; Bhalla et al. 2004; Cenci et al. 2008; Schellekens et al.…”
Serotonin and the regulation of mammalian energy balance
Donovan, M. H., & Tecott, L. H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00036 · Cited by 150
Kawahara, Y., Grimberg, A., Teegarden, S., Mombereau, C., Liu, S., Bale, T. L., Blendy, J. A., & Nishikura, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3896-08.2008 · Cited by 105
Box C/D small nucleolar RNA genes and the Prader‐Willi syndrome: a complex interplay
Cavaillé, J. (2017) · WIREs RNA · doi:10.1002/wrna.1417 · Cited by 86
Metadata
- Authors
- Niswender, C. M., Copeland, S. C., Herrick-Davis, K., Emeson, R. B., & Sanders-Bush, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-04
- Volume
- 274
- Issue
- 14
- Pages
- 9472-9478
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2088211862
- Cited by
- 363
- References
- 28
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.